CGEN FY 2020 Earnings — Compugen Ltd. Revenue & Financial Results | Market Cap Arena

CGENCompugen Ltd.

$215M

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M

Gross Profit

$2M97.0% margin

Operating Income

-$31M-1574.8% margin

Net Income

-$30M-1484.9% margin

EPS (Diluted)

$-0.37

Cash Flow

Operating Cash Flow

-$28M

Free Cash Flow

-$28M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$138M

Total Liabilities

$19M

Stockholders' Equity

$120M

Cash & Equivalents

$7M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$0	—
Gross Profit	$2M	-$989,000	+296.2%
Operating Income	-$31M	-$29M	-9.1%
Net Income	-$30M	-$27M	-8.6%